Hiroshi Nagayama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroshi Nagayama has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Taku Hatano
Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan
4 shared publications - Hirohisa Watanabe
Department of Neurology, Fujita Health University School of Medicine
3 shared publications Tomoaki Kumagai
Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
3 shared publicationsYasuhiro Nishiyama
Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
3 shared publicationsYasuo Katayama
3 shared publicationsHideki Shimura
Department of Neurology, Juntendo University Urayasu Hospital, Urayasu, Japan
2 shared publications
Latest Publications
- Open Access
- 17 April 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 12, 100327
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson’s disease: Subanalysis of the ISTRA ADJUST PD
- 17 April 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 12, 100327
Open AccessImpact of istradefylline on motor and non-motor symptoms in patients with Parkinson’s disease: Subanalysis of the ISTRA ADJUST PD
- 1 August 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 415, 116862
Elevated cardio-ankle vascular index may be related to future stroke risk in Japanese subjects
- 1 August 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 415, 116862
Elevated cardio-ankle vascular index may be related to future stroke risk in Japanese subjects
- 1 January 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 396, 78-83
Effect of istradefylline on mood disorders in Parkinson's disease
- 1 January 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 396, 78-83
Effect of istradefylline on mood disorders in Parkinson's disease
- 1 January 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 372, 403-407
Anhedonia and its correlation with clinical aspects in Parkinson's disease
- 1 January 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 372, 403-407
Anhedonia and its correlation with clinical aspects in Parkinson's disease
- 1 June 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 365, 162-166
A Japanese multicenter survey characterizing pain in Parkinson's disease
- 1 June 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 365, 162-166
A Japanese multicenter survey characterizing pain in Parkinson's disease
- 13 April 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 365, 74-75
Aspirin, but not clopidogrel, ameliorates vasomotor symptoms due to essential thrombocythemia: A case report
- 13 April 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 365, 74-75
Aspirin, but not clopidogrel, ameliorates vasomotor symptoms due to essential thrombocythemia: A case report
- Open Access
- 18 September 2015
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 7 (3) , 181-185
Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease
Introduction: Levodopa (LD) is important in the clinical treatment of Parkinson's disease (PD), and the changes of its pharmacokinetics may affect the clinical outcome. LD is mainly absorbed in the upper intestine; thus, the pharmacokinetics of LD may change after gastrointestinal operation. Here, we present the case of a patient who underwent resection of the intestine and compared his LD pharmacokinetics before and after resection. Case Presentation: A 72-year-old Japanese male PD patient developed jaundice and was diagnosed with cholangiocarcinoma. Pancreaticoduodenectomy was performed and part of the stomach, total duodenum, and part of the jejunum were resected. The patient had been treated with LD, and his pharmacokinetics was checked twice at the age of 68 years. Because LD is absorbed in the duodenum and jejunum, we checked his pharmacokinetics again after the operation. The results before the operation were almost similar; however, in comparison, the area under the curve and peak drug concentration was reduced, and the time-to-peak drug concentration and elimination halftime were elongated after the operation. Conclusion: Physicians must pay attention to the change of LD pharmacokinetics after gastrointestinal operation.
- 18 September 2015
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 7 (3) , 181-185
Open AccessPharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease
Introduction: Levodopa (LD) is important in the clinical treatment of Parkinson's disease (PD), and the changes of its pharmacokinetics may affect the clinical outcome. LD is mainly absorbed in the upper intestine; thus, the pharmacokinetics of LD may change after gastrointestinal operation. Here, we present the case of a patient who underwent resection of the intestine and compared his LD pharmacokinetics before and after resection. Case Presentation: A 72-year-old Japanese male PD patient developed jaundice and was diagnosed with cholangiocarcinoma. Pancreaticoduodenectomy was performed and part of the stomach, total duodenum, and part of the jejunum were resected. The patient had been treated with LD, and his pharmacokinetics was checked twice at the age of 68 years. Because LD is absorbed in the duodenum and jejunum, we checked his pharmacokinetics again after the operation. The results before the operation were almost similar; however, in comparison, the area under the curve and peak drug concentration was reduced, and the time-to-peak drug concentration and elimination halftime were elongated after the operation. Conclusion: Physicians must pay attention to the change of LD pharmacokinetics after gastrointestinal operation.
- 13 January 2014
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 338 (1-2) , 220-222
Hypoglycemia-induced spontaneous unilateral jerking movement in bilateral internal capsule posterior limb abnormalities
- 13 January 2014
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 338 (1-2) , 220-222
Hypoglycemia-induced spontaneous unilateral jerking movement in bilateral internal capsule posterior limb abnormalities
- Open Access
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (8) , 865-869
Validity and Reliability Assessment of a Japanese Version of the Snaith-Hamilton Pleasure Scale
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2012
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 51 (8) , 865-869
Open AccessValidity and Reliability Assessment of a Japanese Version of the Snaith-Hamilton Pleasure Scale
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 March 2011
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 17 (3) , 150-152
Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s disease
- 1 March 2011
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 17 (3) , 150-152
Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s disease